According to Tiziana Life Sciences's latest financial reports the company has $6.59 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $18.12 M | -57.04% |
2021-12-31 | $42.18 M | -35.91% |
2020-12-31 | $65.82 M | 32712.19% |
2019-12-31 | $0.2 M | -97.01% |
2018-12-31 | $6.7 M | 7551.58% |
2017-12-31 | $0.08 M | -98.78% |
2016-12-31 | $7.16 M | -63.34% |
2015-12-31 | $19.54 M | 255.96% |
2014-12-31 | $5.49 M | |
2013-12-31 | $N/A | -100% |
2012-12-31 | $0.05 M | -95.23% |
2011-12-31 | $1.09 M | |
2009-12-31 | $0.07 M | 46.3% |
2008-12-31 | $0.05 M | -97.68% |
2007-12-31 | $2.31 M | 18.5% |
2006-12-31 | $1.95 M | -29.77% |
2005-12-31 | $2.78 M | -1.95% |
2004-12-31 | $2.83 M | -10.77% |
2003-12-31 | $3.18 M | 190.74% |
2002-12-31 | $1.09 M | -45.23% |
2001-12-31 | $1.99 M |